Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Blood Safety
Antihemophilic factor concentrates are not without risk
October 5th, 2006
Antihemophilic factor concentrates are not without risk. According to a recent review from the United States, "Hemophilia is a congenital disorder due to the deficiency of the activity of factor VIII (classical hemophilia A) or IX (Christmas disease or hemophilia B). Bleeding is common and may result in long-term complications or even death." "Bleeding may be treated or prevented by infusion of factor concentrates however these drugs are not without risk. Clinicians often feel ill prepared to provide accurate and impartial information regarding these drugs," said L.A. Valentino and colleagues at Rush University in Chicago. The...
Source: Blood Weekly (2006-10-05)
|
